What is Sanofi Lantus?
Sanofi Lantus is a brand name insulin glargine injection used for subcutaneous injection to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. It is injected once daily at the same time every day to lower the blood sugar levels. Lantus SoloSTAR is the prefilled disposable pen containing 3 mL of insulin glargine.
Sanofi Lantus is manufactured by Sanofi, a leading global pharmaceutical company that is committed to improving health across the globe. Sanofi has a patient support program for Lantus that offers savings cards and support for patients who need financial assistance.
Sanofi has also announced a price cap of $35 per month for Lantus insulin, in an effort to make it more affordable. This decision was made following increasing concerns over the high cost of insulin in the United States. Before this move, Lantus had been one of the most expensive insulins on the market.
Lantus was first approved for use by the US FDA in 2000 and has been widely used in the management of diabetes ever since. While Lantus is generally regarded as a safe and effective treatment for diabetes, it may cause side effects in some patients. Common side effects of Lantus may include hypoglycemia, allergic reactions, and injection site reactions. Patients should always consult their healthcare provider if they experience any side effects or have any questions regarding the use of Lantus.
Overall, Sanofi Lantus is an important medication in the management of diabetes, and Sanofi is committed to supporting patients with this condition. Those who may need help affording Lantus should consider reaching out to Sanofi for support through their patient support program.
Frequently Asked Questions about sanofi lantus
Medications Available
- Adacel® Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Absorbed.
- Admelog® (insulin lispro injection) 100 Units/mL.
- Apidra® (insulin glulisine injection) 100 Units/mL.
- IMOVAX® RABIES Rabies Vaccine (Human Diploid Cell)
- Insulin Glargine® (insulin glargine injection)
Insulin lispro Sanofi is a medicine used to control blood glucose (sugar) levels in adults and children with diabetes who need insulin. It contains the active substance insulin lispro. Insulin lispro Sanofi is a 'biosimilar medicine'.
Fast-acting insulins start working in the body within 30 minutes of being injected. Instead, Lantus is a long-acting insulin. Its onset time is 1.5 to 2 hours. This means the drug begins working in your body within 1.5 to 2 hours after you inject it.
Because Insulin aspart Sanofi is a fast-acting insulin, it is usually given shortly before a meal or if more appropriate, soon after a meal. Insulin aspart Sanofi is normally used in combination with a longer-acting insulin.
And Lantus is only one of the many diabetes medicines made by Sanofi.
Commonly Used Sanofi Products
While Sanofi may be best known as the manufacturer of Ambien, the company makes many other commonly used medicines and over-the-counter products.
ONCE-DAILY LANTUS ® IS THE MOST PRESCRIBED1 LONG-ACTING INSULIN. TESTED, TRUSTED, TAKEN. Every day, millions of people count on once-daily Lantus to help lower their A1C. And Lantus is only one of the many diabetes medicines made by Sanofi.
We're proud of our 100-year legacy in insulin, and we're continuously transforming care for people living with diabetes. Discover our Insulin Campus in Frankfurt, one of the largest insulin production sites in the world.
Lantus is used to improve blood sugar control in adults and children with diabetes mellitus. Lantus is for use in adults with type 1 or type 2 diabetes, and in children at least 6 years old with type 1 diabetes. For type 1 diabetes, Lantus is used together with a short-acting insulin given before meals.
Prescription Lantus® is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar. Do not use Lantus® to treat diabetic ketoacidosis.
OPTISULIN® is the same formulation as Lantus®, so no dose adjustment is required. People living with diabetes should continue using insulin to manage their diabetes as directed by their healthcare professional.
Key takeaways: In December 2021, the FDA approved Rezvoglar (insulin glargine-aglr), the second Lantus biosimilar. As of late 2022, it's considered to be interchangeable with Lantus. Rezvoglar is a long-acting insulin that helps control blood sugar levels.
Protecting public health with vaccines
Sanofi was the first worldwide supplier of the injectable polio vaccine followed by the first influenza, meningitis, and rabies vaccines. Today, our portfolio of vaccines protects half a billion people worldwide.
Lantus
Lantus is one of Sanofi's best selling pharmaceutical products. Its revenue has risen from 2.4 billion euros in 2008 to 6.39 billion euros in 2015, but decreased again to under three billion in 2020. Lantus is an insulin glargine used daily to control blood sugar levels of patients with diabetes.
Insulin glargine: Lantus, Basaglar, and Toujeo all contain insulin glargine and last for at least 24 hours. Toujeo lasts the longest (up to 36 hours). There are also several Lantus biosimilars that have been approved. These include Semglee (insulin glargine-yfgn) and Rezvoglar (insulin glargine-aglr).
Long-term use of Lantus can lead to thickening of fat tissues at the injection site. allergic reactions (swelling under the skin, very low blood pressure, and bronchospasm).
